inmazeb
(atoltivimab, maftivimab, and odesivimab-ebgn)Regeneron Pharmaceuticals, Inc.
Usage: INMAZEB is indicated for treating infections caused by *Orthoebolavirus zairense* in adults and pediatric patients, including neonates born to RT-PCR positive mothers. Its efficacy against other *Orthoebolavirus* species and *Orthomarburgvirus* has not been established. Consider drug susceptibility patterns when using INMAZEB.